CASRN: 14882-18-9
Drug Levels and Effects
Summary of Use during Lactation
Because of the possibility of absorption of salicylate from the breastmilk by the infant, alternate therapies are preferred.[1]
Drug Levels
Maternal Levels. No published information was found on the use of bismuth subsalicylate during breastfeeding. Infant salicylate intake is estimated to be less than 1% of the maternal dose when both drug and metabolite are considered.[2]
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
One case report of metabolic acidosis was caused by salicylate in a 16-day old breastfed infant whose mother was taking aspirin 650 mg every 4 hours for arthritis.[3] However, there was no measurement of salicylate in maternal serum or milk and it is unclear whether the infant had received any salicylate directly.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Diarrhea) Loperamide; (Heartburn) Antacids, Famotidine, Nizatidine, Omeprazole, Pantoprazole
References
- 1.
- Lewis JH, Weingold AB and the Committee of FDA-Related Matters American College of Gastroenterology. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol 1985;80:912-23. [PubMed: 2864852]
- 2.
- Levy G. Salicylate pharmacokinetics in the human neonate. In: Morselli P, Garattini S, Sereni F, eds. Basic and therapeutic aspects of perinatal pharmacology. New York: Raven Press; 1975:319-30.
- 3.
- Clark JH, Wilson WG. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clin Pediatr (Phila) 1981;20:53-4. [PubMed: 7449246]
Substance Identification
Substance Name
Bismuth Subsalicylate
CAS Registry Number
14882-18-9
Drug Class
Breast Feeding
Lactation
Milk, Human
Bismuth
Salicylates
Gastrointestinal Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Publication Details
Publication History
Last Revision: September 15, 2024.
Copyright
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Publisher
National Institute of Child Health and Human Development, Bethesda (MD)
NLM Citation
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Bismuth Subsalicylate. [Updated 2024 Sep 15].